Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients (X-MEN)
A Six-month, Open Labeled, Multi-centered, Observational Study for the Tolerability of Exelon Patch (Rivastigmine) for Patients With Alzheimer's Disease
Sponsor: Bobath Memorial Hospital
A observational or N/A phase clinical study on Alzheimer's Disease, this trial is completed. The trial is conducted by Bobath Memorial Hospital and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bobath Memorial Hospital
- Chung-Ang University Hosptial, Chung-Ang University College of Medicine
- Dong-A University Hospital
- Ewha Womans University
- Hallym University Medical Center
- Hanyang University
- Hanyang University Seoul Hospital
- Inha University Hospital
- Inje University
- Jeju National University
- Konyang University Hospital
- Korea University
- Kwandong University Myongji Hospital
- Kyunghee University Medical Center
- Pusan National University Hospital
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- Seoul St. Mary's Hospital
- SungAe General Hospital
- Wonkwang University Sanbon Medical Center
- Yong-in Hyoja Geriatric Hospital
For direct contact, visit the study record on ClinicalTrials.gov .